News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
BioPharm Executive - Karl Thiel
BioPharm Executive: 5 Reasons To Hate Biotech 10/29/2014
BioPharm Executive: Building Biotech's Next Boom 9/24/2014
BioPharm Executive: Attack Of The Job-Stealing Robots 8/27/2014
BioPharm Executive: Job Inversion: The Impact of Pharma Offshoring 6/25/2014
Back To The Future: The Revenge Of Gene Therapy 5/29/2014
Job Seekers Take Notice: Pharma Megamergers Could Be Back 4/30/2014
BioPharm Executive: Eli Lilly and Company (LLY) CEO: Unqualified Scientists In The STEM Market 2/26/2014
BioPharm Executive: Will 2014 Be The Year For RNA Companies? 1/29/2014
BioPharm Executive: Lucky 2013: The Biotech Year In Review 12/18/2013
BioPharm Executive: The Coming Antibiotic Crisis: Should Biotech Follow Its Gut? 11/27/2013
BioPharm Executive: Layoffs Haunt Biotech as Dust Settles After Shutdown 10/31/2013
BioPharm Executive: Google Inc.'s Mysterious Calico Thinks It Can Cheat Death 9/25/2013
BioPharm Executive: Not All States are Biosimilar 8/28/2013
BioPharm Executive: Bribery, Fraud, Deceit--Just Another Day in Pharmaland 7/31/2013
BioPharm Executive: Here's to Elan Corporation PLC (ELN): Is it a Toast or a Wake? 6/26/2013
BioPharm Executive: Manufacturing Trouble: Moving From Crisis to Crisis 5/29/2013
BioPharm Executive: Myriad Genetics, Inc. (MYGN), Glivec, and the $1 Billion "Myth" 4/25/2013
BioPharm Executive: Speaking the Unspeakable 3/27/2013
BioPharm Executive: The End Is Near 2/27/2013
BioPharm Executive: Good Things Ahead 1/30/2013
BioPharm Executive: 2012 in Review 12/19/2012
BioPharm Executive: Pharma Embraces Emerging Markets; They Don't Embrace Back 9/26/2012
BioPharm Executive: Patent Threats, and the Cheap Cost of R&D 8/30/2012
BioPharm Executive: 6 Ways to Save Biotech 7/25/2012
BioPharm Executive: The Price of Togetherness 6/27/2012
BioPharm Executive: Your American Society of Clinical Oncology Crib Sheet 5/30/2012
BioPharm Executive: Shareholders Before Patients? 4/25/2012
BioPharm Executive: Smaller is Smarter 3/28/2012
BioPharm Executive: Bubble, Billions, or Both? 2/29/2012
BioPharm Executive: Embracing Generics and Emerging Markets 1/25/2012
BioPharm Executive: Top 10: 2011 in Review 12/14/2011
BioPharm Executive: The Bad Old Days in Europe? 11/30/2011
BioPharm Executive: FDA Gets the Message 10/26/2011
BioPharm Executive: Too Big to Succeed? 9/29/2011
BioPharm Executive: The Price of Confusion 9/1/2011
BioPharm Executive: FDA, Faster Than Ever? 7/28/2011
BioPharm Executive: Everything You Wanted to Know About ASCO (But Were Afraid to ASCO) 5/25/2011
Biopharm Executive: Too Big to Be Responsible? 4/28/2011
BioPharm Executive: Pure, Small Pharma 3/30/2011
BioPharm Executive: We're All In This Together 2/23/2011
BioPharm Executive: Going Mobile 1/27/2011
BioPharm Executive: Top 10: 2010 In Review 12/15/2010
BioPharm Executive: The Acceleration of Disgust 11/24/2010
BioPharm Executive: Lilly's Shopping Plans Go Against the Grain 10/27/2010
BioPharm Executive: Is Cancer's "Penicillin Moment" FDA's Moment of Doubt? 9/29/2010
BioPharm Executive: Lilly, By Any Other Name... 8/25/2010
BioPharm Executive: Firing Slows, but Lilly Fans the Flames 7/29/2010
BioPharm Executive: Clean Up Your Act 6/30/2010
BioPharm Executive: Hurry Up and Wait 4/28/2010
BioPharm Executive: The New Decade Finally Begins 3/31/2010
BioPharm Executive: This Is Recovery: Less Money, Less Risk Appetite, Fewer Jobs 2/24/2010
BioPharm Executive: J.P. Morgan Healthcare Conference Sets the Tone for 2010 1/27/2010
BioPharm Executive: Top 10: 2009 In Review 12/21/2009
BioPharm Executive: Where'd the Jobs Go? 11/25/2009
BioPharm Executive: No Sleep, But Plenty of REMS 10/28/2009
BioPharm Executive: Vivus: Savior of the Pharma Industry? 9/30/2009
BioPharm Executive: Biotech's Dog Days 8/26/2009
BioPharm Executive: Sunshine, Lollipops, and Exclusivity 7/21/2009
BioPharm Executive: Sprinting to the Finish 6/30/2009
BioPharm Executive: Biotech's Green Shoots 5/27/2009
BioPharm Executive: We Are All Activists Now 4/29/2009
BioPharm Executive -- Biogenerics: The Time Has Come 3/31/2009
BioPharm Executive: Big Pharma's Musical Chairs 2/25/2009
BioPharm Executive: Off On the Right Hand in 2009 1/28/2009
BioPharm Executive Top 10: 2008 in Review 12/18/2008
BioPharm Executive: Change Comes to Biotech 11/25/2008
BioPharm Executive: No Free Lunch 10/29/2008
BioPharm Executive: There Goes Wall Street 9/30/2008
BioPharm Executive: Biotech Money Goes to Democrats (Plus the Stupid Drug Name Olympics) 8/27/2008
BioPharm Executive: Rethink Everything 7/30/2008
Small is Beautiful -- BioPharm Executive 6/25/2008
Taking the Gloves Off 5/26/2008
Biotech Blossoms Anew 4/30/2008
Time to Buy Biotech? 3/26/2008
Biogenerics in '08? 2/26/2008
Keeping Your Hands Clean 1/23/2008
Desperate But Not Crazy 12/20/2007
Dinosaurs and Drug Companies 11/20/2007
Party Like It's 1999 10/23/2007



//-->